Shamik J. Parikh
Chief Medical Officer · Humacyte, Inc.
- 2025
- May 20, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Shamik J. Parikh files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Kathleen Sebelius - $50K in HUMA purchases and sales in the last 12 months
- Dale A. Sander - $41K in HUMA purchases and sales in the last 12 months
- Keith Anthony Jones - $30K in HUMA purchases and sales in the last 12 months
- Michael T. Constantino - $10K in HUMA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Shamik J. Parikh?
Shamik J. Parikh is a corporate insider, tracked as Chief Medical Officer of Humacyte, Inc. (HUMA). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Shamik J. Parikh last file a Form 4?
The most recent primary Form 4 on record is dated 20 May 2026, one of 2 filings going back to 2025.
Has Shamik J. Parikh been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($41K) across all tracked filings.
